The Hot Stock: Merck Gains 5.8%
January 16, 2018 at 16:30 PM EST
Data from the latest trial of Merck's blockbuster cancer treatment helped propel the stock to the top of the S&P 500 Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.